Millions could gain easier access to popular peptides after FDA panel vote
The clinician said she incorporates select peptides into her own practice “when appropriate with informed consent and careful monitoring.”
“I’m always looking for more data that helps us better identify which patients are most likely to benefit,” she said. “I encourage patients to approach all investigational peptides with the same level of caution – many have compelling mechanistic or pre-clinical data, but human evidence remains limited.”
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Although many of these peptides are “supported by a compelling biological rationale,” Kahn stressed that treatment decisions should be individualized and “made with a physician who understands both the potential benefits, risks and uncertainties.”
Angelica Stabile is a lifestyle reporter for Fox News Digital.
Article source: https://www.foxnews.com/health/millions-gain-easier-access-popular-peptides-after-fda-panel-vote